Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Plans to also open a new bioanalytical lab at the facility.
February 4, 2025
By: Charlie Sternberg
Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) with facilities in Belgium, Spain, the Netherlands, and Sweden, has completed its acquisition of Catalent’s drug product manufacturing facility in Somerset, New Jersey.
This acquisition marks a significant milestone in Ardena’s strategic expansion into North America, strengthening its capabilities in late-stage and small-scale commercial manufacturing of oral drug products and further integrating its comprehensive suite of drug development services.
The Somerset, NJ facility encompasses over 50,000 sq ft of cGMP manufacturing space and is home to 200+ skilled scientists and technicians. It is a recognized Center of Excellence for advanced oral dosage forms, specializing in modified-release formulations, Hot Melt Extrusion for enhanced bioavailability, and the handling of controlled substances.
These capabilities complement Ardena’s existing expertise in Europe, enabling the delivery of tailored solutions to pharmaceutical and biotechnology companies worldwide.
Additionally, Ardena is expanding its Bioanalytical Services in North America by opening a brand-new bioanalytical lab at the Somerset facility.
The initial investment will include a new 2,500+ sq ft lab, expected to be operational by Q3 2025, providing advanced analytical testing services for both small and large molecules, mirroring Ardena’s European capabilities in immunochemistry, LC-MS/MS, flow cytometry, and qPCR platforms. This new lab will provide enhanced support for global clinical trials programs.
“This acquisition reflects our ongoing commitment to supporting biopharma innovators at every stage of drug development,” said Jeremie Trochu, CEO of Ardena. “The addition of the Somerset facility strengthens our ability to provide tailored, high-quality development and manufacturing solutions to our clients while accelerating the international expansion of our fast-growing bioanalytical business.”
Trochu added: “We are thrilled to officially welcome the Somerset team into the Ardena family. Their deep scientific and technical expertise, their impeccable regulatory track record, and unwavering dedication to excellence align perfectly with our mission of helping clients bring life-changing treatments to patients quickly and efficiently.”
Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !